Psychiatrists are to give official recognition to dozens of new mental disorders, including a condition nicknamed “Mary Whitehouse syndrome” — the thrill of being appalled by pornography and other obscenities…. The condition is one of many mood disorders and personality traits that are likely to be added to the next edition of the psychiatrists’ “bible”.
Critics say there’s a damaging conflict of interest with the financial ties between drug companies and experts who are revising the Diagnostic and Statistical Manual of Mental Disorders (DSM-V), as well as guidelines on the best treatments. This question has been a big topic of debate not just in scientific and academic journals it also concerns the public welfare.
The American Psychiatric Association’s release of the proposed fifth revision of its billing bible, the Diagnostic and Statistical Manual of Mental Disorders (DSM) fuels University of California’s Dr. Irwin Savodnik’s statement, “The very vocabulary of psychiatry is now defined at all levels by the pharmaceutical industry.”
The American Psychiatric Association yesterday gave the press an advance view of its proposed Diagnostic and Statistical Manual of Mental Disorders, and the reports were highly skeptical. Will Tiger Woods soon be diagnosed with “hypersexual disorder”? He could be if the proposals go into effect. The APA will be accepting comments through April. The news reports barely noted the fact that dozens of psychiatrists who serve on the DSM-V (it’s the fifth edition) task force and working groups have financial ties to the pharmaceutical and medical device industries.
With drug giant GlaxoSmithKline (GSK) now stating it will abandon future antidepressant research, one can only wonder if the U.S. Food and Drug Administration noted GSK’s CEO Andrew Witty’s admission that it is “hard to prove that a depression drug is working” because “patient improvement is measured by subjective mood surveys, and not by the clear-cut blood tests and biological measures used in other diseases.”